Researchers have identified a set of previously unknown mutations in a single gene in 8 percent of neuroblastomas, tumors of the nervous system that occur in young children and account for approximately 15 percent of all childhood cancer deaths. The discovery is intriguing because a small “targeted” molecule inhibitor caused neuroblastoma cell lines carrying two of the mutations to die when treated in the laboratory.